UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 29, 2017 (December 28, 2017)
MYOS RENS TECHNOLOGY INC.
(Exact name of registrant as specified in its charter)
| Nevada | 000-53298 | 90-0772394 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
45 Horsehill Road, Suite 106 Cedar Knolls, New Jersey |
07927 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant's telephone number, including area code (973) 509-0444
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.07. | Submission of Matters to a Vote of Security Holders. |
On December 28, 2017, MYOS RENS Technology Inc. (the “Company”) held its 2017 annual meeting of stockholders (the “Meeting”). At the Meeting, stockholders (i) elected two directors to serve as Class II directors on the Company’s board of directors (“Board”) until the 2020 annual meeting of stockholders or until their successors are elected and qualified and (ii) ratified the selection by the Board of Withum Smith+Brown, PC (“Withum”) to serve as the Company’s independent registered public accounting firm for the year ending December 31, 2017.
Set forth below are the final voting results for each of the proposals:
Proposal No. 1 – Election of directors
Dr. Louis J. Aronne and Christopher Pechock were elected to serve as Class II directors. The voting results were as follows:
| Name | For | Withheld | Broker Non-Vote | |||
| Dr. Louis J. Aronne | 839,856 | 298,687 | 2,017,206 | |||
| Christopher Pechock | 863,467 | 275,076 | 2,017,206 |
Proposal No. 2 – Ratification of independent registered public accounting firm
The stockholders ratified the selection of Withum to serve as the Company’s independent registered public accounting firm for the year ending December 31, 2017. The voting results were as follows:
| For | Against | Abstentions | ||
| 2,978,805 | 4,666 | 209,850 |
| 1 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MYOS RENS TECHNOLOGY, INC. | ||
| Dated: December 29, 2017 | By: | /s/ Joseph Mannello |
| Name: | Joseph Mannello | |
| Title: | Chief Executive Officer | |
2